메뉴 건너뛰기




Volumn 59, Issue 4, 2012, Pages

Pharmacologic prophylaxis for acute mountain sickness: A systematic shortcut review

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DEXAMETHASONE; GABAPENTIN; GINKGO BILOBA EXTRACT; MAGNESIUM CITRATE; PLACEBO; SUMATRIPTAN; THIOCTIC ACID;

EID: 84859100249     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2011.10.015     Document Type: Article
Times cited : (32)

References (21)
  • 1
    • 0034729996 scopus 로고    scopus 로고
    • Efficacy and harm of pharmacological prevention of acute mountain sickness: Quantitative systematic review
    • L. Dumont, C. Mardirosoff, M.R. Tramer Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review BMJ 321 2000 267 272 (Pubitemid 30487464)
    • (2000) British Medical Journal , vol.321 , Issue.7256 , pp. 267-272
    • Dumont, L.1    Mardirosoff, C.2    Tramer, M.R.3
  • 2
  • 3
    • 0017109687 scopus 로고
    • The incidence, importance, and prophylaxis of acute mountain sickness
    • P.H. Hackett, D. Rennie, H.D. Levine The incidence, importance, and prophylaxis of acute mountain sickness Lancet 2 1976 1149 1155
    • (1976) Lancet , vol.2 , pp. 1149-1155
    • Hackett, P.H.1    Rennie, D.2    Levine, H.D.3
  • 5
    • 84866732628 scopus 로고    scopus 로고
    • Accessed July 15, 2011
    • Emergency Medical Abstracts http://www.emaonline.org Accessed July 15, 2011
    • Emergency Medical Abstracts
  • 7
    • 33646093759 scopus 로고    scopus 로고
    • Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE
    • S.S.L. Wong, N.L. Wilczynski, R.B. Haynes Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE J Med Libr Assoc 94 2006 41 47
    • (2006) J Med Libr Assoc , vol.94 , pp. 41-47
    • Wong, S.S.L.1    Wilczynski, N.L.2    Haynes, R.B.3
  • 9
    • 0037367823 scopus 로고    scopus 로고
    • Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial
    • B. Basnyat, J.H. Gertsch, E.W. Johnson et al. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial High Alt Med Biol 4 2003 45 52 (Pubitemid 36511798)
    • (2003) High Altitude Medicine and Biology , vol.4 , Issue.1 , pp. 45-52
    • Basnyat, B.1    Gertsch, J.H.2    Johnson, E.W.3    Castro-Marin, F.4    Inoue, Y.5    Yeh, C.6
  • 12
    • 77956473650 scopus 로고    scopus 로고
    • Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: The Headache Evaluation at Altitude Trial (HEAT)
    • J.H. Gertsch, G.S. Lipman, P.S. Holck et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT) Wilderness Environ Med 21 2010 236 243
    • (2010) Wilderness Environ Med , vol.21 , pp. 236-243
    • Gertsch, J.H.1    Lipman, G.S.2    Holck, P.S.3
  • 13
    • 79952299742 scopus 로고    scopus 로고
    • Spironolactone does not prevent acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group)
    • B. Basnyat, P.S. Holck, M. Pun et al. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group) Wilderness Environ Med 22 2011 15 22
    • (2011) Wilderness Environ Med , vol.22 , pp. 15-22
    • Basnyat, B.1    Holck, P.S.2    Pun, M.3
  • 15
    • 34948847615 scopus 로고    scopus 로고
    • Sumatriptan for prevention of acute mountain sickness: Randomized clinical trial
    • DOI 10.1002/ana.21162
    • S. Jafarian, F. Gorouhi, S. Salimi et al. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial Ann Neurol 62 2007 273 277 (Pubitemid 47525403)
    • (2007) Annals of Neurology , vol.62 , Issue.3 , pp. 273-277
    • Jafarian, S.1    Gorouhi, F.2    Salimi, S.3    Lotfi, J.4
  • 16
    • 33645651531 scopus 로고    scopus 로고
    • Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: The Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) trial
    • B. Basnyat, J.H. Gertsch, P.S. Holck et al. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) trial High Alt Med Biol 7 2006 17 27
    • (2006) High Alt Med Biol , vol.7 , pp. 17-27
    • Basnyat, B.1    Gertsch, J.H.2    Holck, P.S.3
  • 17
    • 1842506452 scopus 로고    scopus 로고
    • Randomised, double blind, placebo controlled comparison of Ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: The Prevention of High Altitude Illness Trial (PHAIT)
    • J.H. Gertsch, B. Basnyat, E.W. Johnson et al. Randomised, double blind, placebo controlled comparison of Ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the Prevention of High Altitude Illness Trial (PHAIT) BMJ 328 2004 797
    • (2004) BMJ , vol.328 , pp. 797
    • Gertsch, J.H.1    Basnyat, B.2    Johnson, E.W.3
  • 18
    • 65449175766 scopus 로고    scopus 로고
    • Oral antioxidant supplementation does not prevent acute mountain sickness: Double blind, randomized placebo-controlled trial
    • J.K. Baillie, A.A.R. Thompson, J.B. Irving et al. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial QJM 102 2009 341 348
    • (2009) QJM , vol.102 , pp. 341-348
    • Baillie, J.K.1    Thompson, A.A.R.2    Irving, J.B.3
  • 19
    • 84859107006 scopus 로고    scopus 로고
    • Altitude sickness
    • D. Murdoch Altitude sickness Clin Evid 3 2010 1 11
    • (2010) Clin Evid , vol.3 , pp. 1-11
    • Murdoch, D.1
  • 20
    • 58149263352 scopus 로고    scopus 로고
    • Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness
    • M.C.T. van Patot, G. Leadbetter, L.E. Keyes et al. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness High Alt Med Biol 9 2008 289 293
    • (2008) High Alt Med Biol , vol.9 , pp. 289-293
    • Van Patot, M.C.T.1    Leadbetter, G.2    Keyes, L.E.3
  • 21
    • 13444300988 scopus 로고    scopus 로고
    • Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: A randomized, placebo-controlled trial
    • DOI 10.1001/archinte.165.3.296
    • T. Chow, V. Browne, H.L. Heileson et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial Arch Intern Med 165 2005 296 301 (Pubitemid 40216282)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.3 , pp. 296-301
    • Chow, T.1    Browne, V.2    Heileson, H.L.3    Wallace, D.4    Anholm, J.5    Green, S.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.